Zai Lab Ltd (HK:9688) has released an update.
Zai Lab Limited has reported a significant 42% increase in net product revenue, reaching $187.3 million, largely due to robust sales of its products like VYVGART. Despite rising sales, the company managed to reduce its net loss by 21% to $133.7 million, benefitting from a decrease in research and development expenses and foreign currency losses. The interim financial results, complying with U.S. GAAP, indicate a promising outlook for the company with a decrease in basic and diluted loss per share from $0.18 to $0.14.
For further insights into HK:9688 stock, check out TipRanks’ Stock Analysis page.
